The company provides comprehensive manufacturing of polymer compounds, which are blended to generate bespoke components for use in the medical device and diagnostics sector.
Additionally, it supplies product development services to create high-quality tailored products according to the needs of the customer.
The company utilises state-of-the-art equipment for in-house batch testing and product development, including FT/IR spectroscopy, X-ray spectroscopy, and colour analysis.
The company is offered for sale to facilitate retirement plans.
Established reputation with a strong customer base and prominence within the medical and diagnostics industry.
An ideal acquisition opportunity for similar businesses to integrate the company’s range of products into their existing offering.
Skilled and experienced workforce in place.
Significant scope to encourage growth through the recruitment of skilled personnel.
Directors willing to assist with handover period.
Operates from leasehold premises.
Turnover of circa £2.2 million in YE23.
Adjusted EBITDA of over £532k achieved in the same year.
Forecast turnover of over £2.3 million in YE24.
Projected turnover of over £2.4 million in YE25.
Robust and consistent gross profit margins.
Well-established within its sector, with high levels of repeat and return business.
In discussion with a major client for upcoming pipeline of work with work over £108k in YE24.
Has recently secured work with which will repeat in 2025.
Offers invited.
